• Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

Gilead Agrees to Allow Generic Version of Groundbreaking H.I.V. Shot in Poor Countries

Many middle-income countries are left out of the deal, widening a gulf in access to critical medicines.

Stephanie Nolen
Author: Stephanie Nolen

Written by

Stephanie Nolen

in

Brazil, China, Colombia, Developing Countries, Drugs (Pharmaceuticals), Epidemics, Generic Brands and Products, Gilead Sciences Inc, Intellectual Property, Inventions and Patents, lenacapavir, Medicine and Health, Prices (Fares, Fees and Rates)
←A GOP Congressman Tweeted A JD Vance Image That Must Be Seen To Be Believed
JD Vance Defends His Alarming Debate Answer About The 2020 Election Results→

More posts

  • Several dead after postal bus bursts into flames, authorities say

  • Dallas athlete returns home after witnessing Tehran strikes

  • WATCH: WNBA season up in the air as CBA negotiations deadline closes in

  • Large US special ops force needed on ground to seize Iran’s uranium, experts say

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube